Standardizing Clinically Meaningful Outcome Measures Beyond HbA(1c) for Type 1 Diabetes: A Consensus Report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, The Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange

OBJECTIVE: To identify and define clinically meaningful type 1 diabetes outcomes beyond hemoglobin A(1c) (HbA(1c)) based upon a review of the evidence, consensus from clinical experts, and input from researchers, people with type 1 diabetes, and industry. Priority outcomes include hypoglycemia, hype...

Descripción completa

Detalles Bibliográficos
Autores principales: Agiostratidou, Gina, Anhalt, Henry, Ball, Dana, Blonde, Lawrence, Gourgari, Evgenia, Harriman, Karen N., Kowalski, Aaron J., Madden, Paul, McAuliffe-Fogarty, Alicia H., McElwee-Malloy, Molly, Peters, Anne, Raman, Sripriya, Reifschneider, Kent, Rubin, Karen, Weinzimer, Stuart A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2017
Materias:
Continuous Glucose Monitoring and Risk of Hypoglycemia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5864122/
https://www.ncbi.nlm.nih.gov/pubmed/29162582
http://dx.doi.org/10.2337/dc17-1624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5864122/
https://www.ncbi.nlm.nih.gov/pubmed/29162582
http://dx.doi.org/10.2337/dc17-1624

Ejemplares similares